Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-20T17:26:19.817Z Has data issue: false hasContentIssue false
  • English
  • Français

Delirium in advanced age and dementia: A prolonged refractory course of delirium and lower functional status

Published online by Cambridge University Press:  05 September 2014

Soenke Boettger ,
Josef Jenewein  and
William Breitbart
Soenke Boettger*
Affiliation:
Department of Psychiatry and Psychotherapy, University Hospital Zurich, Zurich, Switzerland
Josef Jenewein
Affiliation:
Department of Psychiatry and Psychotherapy, University Hospital Zurich, Zurich, Switzerland
William Breitbart
Affiliation:
Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York
*
Address correspondence and reprint requests to: Soenke BoettgermUniversity Hospital Zurich, Ramistrasse 100, CH-8091 Zurich, Switzerland. E-mail: [email protected].
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

The factors associated with persistent delirium, in contrast to resolved delirium, have not been studied well. The aim of our present study was to identify the factors associated with delirium resolution as measured by the Memorial Delirium Assessment Scale (MDAS) and functional improvement as measured by the Karnofsky Performance Status (KPS) scale.

Method:

All subjects were recruited from psychiatric referrals at the Memorial Sloan Kettering Cancer Center (MSKCC). The two study instruments were performed at baseline (T1), at 2–3 days (T2), and at 4–7 days (T3). Subjects with persistent delirium were compared to those with resolved delirium in respect to sociodemographic and medical variables.

Results:

Overall, 26 out of 111 patients had persistent delirium. These patients were older, predominantly male, and had more frequently preexisting comorbid dementia. Among cancer diagnoses and stage of illness, brain cancer and terminal illness contributed to persistent delirium or late response, whereas gastrointestinal cancer was associated with resolved delirium. Among etiologies, infection responded late to delirium management, usually at one week. Furthermore, delirium was more severe in patients with persistent delirium from baseline through one week. At baseline, MDAS scores were 20.1 in persistent delirium compared to 17 to 18.8 in resolved delirium (T2 and T3), and at one week of management (T3), MDAS scores were 15.2 and 4.7 to 7.4, respectively. At one week of management, persistent delirium manifested in more severe impairment in the domains of consciousness, cognition, organization, perception, psychomotor behavior, and sleep–wake cycle. In addition, persistent delirium caused more severe functional impairment.

Significance of results:

In this delirium sample, advanced age and preexisting dementia, as well as brain cancer, terminal illness, infection, and delirium severity contributed to persistent delirium or late response, indicating a prolonged and refractory course of delirium, in addition to more severe functional impairment through one week of management.

Keywords

AgeDementiaPersistent deliriumCourse of deliriumAntipsychoticsCancer
Type
Original Articles
Information
Palliative & Supportive Care , Volume 13 , Issue 4 , August 2015 , pp. 1113 - 1121
Copyright
Copyright © Cambridge University Press 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Alexopoulos, G.S., Streim, J., Carpenter, D., et al. (2004). Using antipsychotic agents in older patients. Journal of Clinical Psychiatry, 65(Suppl. 2), 5–99; discussion 100–102; quiz 103–104.Google Scholar
American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders, 4th ed., Text revision (DSM–IV–TR). Washington, DC: American Psychiatric Association.Google Scholar
Bond, S.M., Neelon, V.J. & Belyea, M.J. (2006). Delirium in hospitalized older patients with cancer. Oncology Nursing Forum, 33, 1075–1083.CrossRefGoogle ScholarPubMed
Breitbart, W. & Strout, D. (2000). Delirium in the terminally ill. Clinics in Geriatric Medicine, 16, 357–372.Google Scholar
Breitbart, W., Rosenfeld, B., Roth, A., et al. (1997). The Memorial Delirium Assessment Scale. Journal of Pain and Symptom Management, 13, 128–137.Google Scholar
Breitbart, W., Tremblay, A. & Gibson, C. (2002). An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients. Psychosomatics, 43, 175–182.CrossRefGoogle ScholarPubMed
Bucht, G., Gustafson, Y. & Sandberg, O. (1999). Epidemiology of delirium. Dementia and Geriatric Cognitive Disorders, 10, 315–318.CrossRefGoogle ScholarPubMed
Camus, V., Gonthier, R., Dubos, G., et al. (2000). Etiologic and outcome profiles in hypoactive and hyperactive subtypes of delirium. Journal of Geriatric Psychiatry and Neurology, 13, 38–42.Google Scholar
Cole, M.G. (2004). Delirium in elderly patients. American Journal of Geriatric Psychiatry, 12, 7–21.Google Scholar
DeLeon, A., Patel, N.C. & Crismon, M.L. (2004). Aripiprazole: A comprehensive review of its pharmacology, clinical efficacy, and tolerability. Clinical Therapeutics, 26, 649–666.CrossRefGoogle ScholarPubMed
Fong, T.G., Jones, R.N., Shi, P., et al. (2009 a). Delirium accelerates cognitive decline in Alzheimer disease. Neurology, 72, 1570–1575.Google Scholar
Fong, T.G., Tulebaev, S.R. & Inouye, S.K. (2009 b). Delirium in elderly adults: Diagnosis, prevention and treatment. Nature Reviews. Neurology, 5, 210–220.CrossRefGoogle ScholarPubMed
Francis, J., Martin, D. & Kapoor, W.N. (1990). A prospective study of delirium in hospitalized elderly. The Journal of the American Medical Association, 263, 1097–1101.CrossRefGoogle ScholarPubMed
Gaudreau, J.D., Gagnon, P., Harel, F., et al. (2005). Psychoactive medications and risk of delirium in hospitalized cancer patients. Journal of Clinical Oncology, 23, 6712–6718.Google Scholar
Inouye, S.K. (1998). Delirium in hospitalized older patients. Clinics in Geriatric Medicine, 14, 745–764.Google Scholar
Inouye, S.K. (2006). Delirium in older persons. The New England Journal of Medicine, 354, 1157–1165.Google Scholar
Inouye, S.K., Zhang, Y., Jones, R.N., et al. (2007). Risk factors for delirium at discharge: Development and validation of a predictive model. Archives of Internal Medicine, 167, 1406–1413.Google Scholar
Jeste, D.V., Blazer, D., Casey, D., et al. (2008). ACNP white paper: Update on use of antipsychotic drugs in elderly persons with dementia. Neuropsychopharmacology, 33, 957–970.Google Scholar
Karnofsky, D.A. & Burchenal, J.H. (1949). The clinical evaluation of chemotherapeutic agents in cancer. In Evaluation of chemotherapeutic agents. Macleod, C.M. (ed.), pp. 191–205. New York: Columbia University Press.Google Scholar
Kazmierski, J., Kowman, M., Banach, M., et al. (2008). Clinical utility and use of DSM–IV and ICD–10 criteria and the Memorial Delirium Assessment Scale in establishing a diagnosis of delirium after cardiac surgery. Psychosomatics, 49, 73–76.Google Scholar
Kelly, K.G., Zisselman, M., Cutillo-Schmitter, T., et al. (2001). Severity and course of delirium in medically hospitalized nursing facility residents. American Journal of Geriatric Psychiatry, 9, 72–77.Google Scholar
Kiely, D.K., Jones, R.N., Bergmann, M.A., et al. (2006). Association between delirium resolution and functional recovery among newly admitted post-acute facility patients. The Journals of Gerontology, Series A, 61, 204–208.Google Scholar
Kiely, D.K., Marcantonio, E.R., Inouye, S.K., et al. (2009). Persistent delirium predicts greater mortality. Journal of the American Geriatrics Society, 57, 55–61.Google Scholar
Koponen, H., Stenback, U., Mattila, E., et al. (1989). Delirium among elderly persons admitted to a psychiatric hospital: Clinical course during the acute stage and one-year follow-up. Acta Psychiatrica Scandinavica, 79, 579–585.Google Scholar
Lawlor, P.G., Gagnon, B., Mancini, I.L., et al. (2000 a). Occurrence, causes, and outcome of delirium in patients with advanced cancer: A prospective study. Archives of Internal Medicine, 160, 786–794.Google Scholar
Lawlor, P.G., Nekolaichuk, C., Gagnon, B., et al. (2000 b). Clinical utility, factor analysis, and further validation of the memorial delirium assessment scale in patients with advanced cancer: Assessing delirium in advanced cancer. Cancer, 88, 2859–2867.Google Scholar
Lee, K.H., Ha, Y.C., Lee, Y.K., et al. (2011). Frequency, risk factors, and prognosis of prolonged delirium in elderly patients after hip fracture surgery. Clinical Orthopedics and Related Research, 469, 2612–2620.CrossRefGoogle ScholarPubMed
Levkoff, S.E. & Marcantonio, E.R. (1994). Delirium: A major diagnostic and therapeutic challenge for clinicians caring for the elderly. Comprehensive Therapy, 20, 550–557.Google Scholar
Levkoff, S.E., Evans, D.A., Liptzin, B., et al. (1992). Delirium: The occurrence and persistence of symptoms among elderly hospitalized patients. Archives of Internal Medicine, 152, 334–340.CrossRefGoogle ScholarPubMed
Levkoff, S.E., Liptzin, B., Evans, D.A., et al. (1994). Progression and resolution of delirium in elderly patients hospitalized for acute care. The American Journal of Geriatric Psychiatry, 2, 230–238.Google Scholar
Lipowski, Z.J. (1989). Delirium in the elderly patient. The New England Journal of Medicine, 320, 578–582.Google Scholar
Ljubisavljevic, V. & Kelly, B. (2003). Risk factors for development of delirium among oncology patients. General Hospital Psychiatry, 25, 345–352.CrossRefGoogle ScholarPubMed
Manos, P.J. & Wu, R. (1997). The duration of delirium in medical and postoperative patients referred for psychiatric consultation. Annals of Clinical Psychiatry, 9, 219–226.Google Scholar
Marcantonio, E., Ta, T., Duthie, E., et al. (2002). Delirium severity and psychomotor types: Their relationship with outcomes after hip fracture repair. Journal of the American Geriatrics Society, 50, 850–857.Google Scholar
Massie, M.J., Holland, J. & Glass, E. (1983). Delirium in terminally ill cancer patients. The American Journal of Psychiatry, 140, 1048–1050.Google Scholar
McCusker, J., Cole, M., Dendukuri, N., et al. (2001). Delirium in older medical inpatients and subsequent cognitive and functional status: A prospective study. Canadian Medical Association Journal, 165, 575–583.Google ScholarPubMed
McCusker, J., Cole, M., Dendukuri, N., et al. (2003). The course of delirium in older medical inpatients: A prospective study. Journal of General Internal Medicine, 18, 696–704.Google Scholar
McNicoll, L., Pisani, M.A., Zhang, Y., et al. (2003). Delirium in the intensive care unit: Occurrence and clinical course in older patients. Journal of the American Geriatrics Society, 51, 591–598.CrossRefGoogle ScholarPubMed
Rahkonen, T., Makela, H., Paanila, S., et al. (2000). Delirium in elderly people without severe predisposing disorders: Etiology and 1-year prognosis after discharge. International Psychogeriatrics, 12, 473–481.CrossRefGoogle ScholarPubMed
Rothberg, M.B., Herzig, S.J., Pekow, P.S., et al. (2013). Association between sedating medications and delirium in older inpatients. Journal of the American Geriatrics Society, 61, 923–930.Google Scholar
Schneider, L.S., Dagerman, K.S. & Insel, P. (2005). Risk of death with atypical antipsychotic drug treatment for dementia: Metaanalysis of randomized placebo-controlled trials. The Journal of the American Medical Association, 19(294), 1934–1943.Google Scholar
Taylor, D.M. (2003). Aripiprazole: A review of its pharmacology and clinical use. International Journal of Clinical Practice, 57, 49–54.Google Scholar
Trzepacz, P.T., Breitbart, W., Franklin, J., et al. (1999). Practice guideline for the treatment of patients with delirium. The American Journal of Psychiatry, 156, 1–20.Google Scholar
Voyer, P., McCusker, J., Cole, M.G., et al. (2007). Factors associated with delirium severity among older patients. Journal of Clinical Nursing, 16, 819–831.CrossRefGoogle ScholarPubMed